AUA 2018 Renal Cancer

Viewing 1-20 of 90 articles

AUA 2018: Trends in Renal Surgery from the National Inpatient Sample: Implications for Resident Education

AUA 2018: Radical Nephrectomy for Recurrent Renal Cell Carcinoma: Patient Selection for Laparoscopic Approach

AUA 2018: ELOC-Mutated Renal Cell Carcinoma: A Distinct Clinical Entity with Unclear Disease Course

AUA 2018: Active Surveillance of T1a Renal Masses: Results from National Cancer Database

AUA 2018: State-of-the-Art Lecture - Disparities in Urology: Renal Transplant

AUA 2018: Crossfire: Controversies in Urology: Kidney Cancer

AUA 2018: Tips and Tricks: Dissection of the Renal Mass with Hilar Fat Invasion

AUA 2018: How Surgical Factors Influence Renal Functional Preservation in Healthy and "At-Risk" Kidneys after Partial Nephrectomy

AUA 2018: Distribution of M0 Renal Cell Carcinoma Metastases Stratified by Pathologic Nodal Status

AUA 2018: Carcinomas Of The Renal Medulla: A Comprehensive Genomic Profiling (Cgp) Study

AUA 2018: Effect of Ketogenic Diet on the Clear Cell Renal Cell Carcinoma Cell Growth

AUA 2018: Somatic Mutation in Mitochrondrial DNA Predicts Postoperative Recurrence in Renal Cell Carcinoma.

AUA 2018: Percutaneous Cryoablation of Renal Tumors in Solitary Kidney: Results From an Italian Multicentric Study

AUA 2018: Safety and Efficacy of Percutaneous US and CT Guided Microwave Ablation of T1a and T1b Renal tumors

AUA 2018: Comparative Analysis of Perioperative Outcomes for Patients With 4-7cm RCC Treated with Either Microwave Ablation, Partial Nephrectomy or Radical Nephrectomy

AUA 2018: Exploration of Biomarkers Associated with Prognosis in Patients with Clear Cell Renal Cell Carcinoma Undergoing Surgical Resection by Desorption Electrospray Ionization Imaging Mass Spectrometry

AUA 2018: Metabolomic Signatures in Urine from Renal Cell Carcinoma Patients

AUA 2018: Estrogen Receptor β Promotes Renal Cell Carcinoma Progression via Regulating LncRNA HOTAIR-miR-138/200c/204/217 Associated CeRNA Network

AUA 2018: Use of Urinary Metabolomics to Identify High-Risk Clear Cell Renal Cell Carcinoma

AUA 2018: Clinicopathological and Survival Analysis of Stage III/IV Papillary and Chromophobe Renal Cell Carcinoma: Implications for Future Clinical Trials

1
2
3
4
5